Effects of single-dose zileuton on bronchial hyperresponsiveness in asthmatic patients treated with inhaled corticosteroids

European Respiratory Journal

Volumn 10, Issue 12, 1997, Pages 2749-2753

  Dekhuijzen, P N R ^a   Bootsma, G P ^a   Wielders, P L M L ^a   Van Den Berg, L R M ^a   Festen, J ^a   Van Herwaarden, C L A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; Bronchial hyperresponsiveness; Inhaled corticosteroids; Lipoxygenase inhibitor; Zileuton

Indexed keywords

CORTICOSTEROID; LIPOXYGENASE INHIBITOR; PLACEBO; ZILEUTON;

ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAINTENANCE THERAPY; MEASUREMENT; PRIORITY JOURNAL; PROVOCATION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HISTAMINE; HUMANS; HYDROXYUREA; LIPOXYGENASE INHIBITORS; MALE; MIDDLE AGED; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; WATER;

EID: 0031464095     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10122749     Document Type: Article

References (31)

1. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332: 868-875.
2. Kamada AK, Szefler SJ, Martin RJ, et al. Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 1996; 153: 1739-1748.
3. Tagari P, Brideau C, Chan C, Frenette R, Black C, Ford Hutchinson A. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors. Actions Agents 1993; 40: 62-71.
4. Bell RL, Lanni C, Malo PE, et al. Preclinical and clinical activity of zileuton and A-78773. Ann NY Acad Sci 1993; 696: 205-215.
5. Drazen JM, Israel E. Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway. Int Arch Allergy Immunol 1995; 107: 319-320.
6. McGill KA, Busse WW. Zileuton. Lancet 1996; 348: 519-524.
7. Israel E, Dermarkarian R, Rosenberg M, et al. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med 1990; 323: 1740-1744.
8. Hui KP, Taylor IK, Taylor GW, et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991; 46: 184-189.
9. Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993; 148: 1447-1451.
10. Meltzer SS, Hasday JD, Cohn J, Bleecker ER. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996; 153: 931-935.
11. Fischer AR, McFadden CA, Frantz R, et al. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med 1995; 152: 1203-1207.
12. Israel E, Rubin P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993; 119: 1059-1066.
13. Israel E, Conn J, Dube L, Drazen JM. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: a randomized controlled trial. Zileuton Clinical Trial Group. JAMA 1996; 275: 931-936.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
15. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327: 1413-1419.
16. Quanjer PH. Standardized Lung Function Testing. Report Working Party "Standardization of Lung Function Tests" of the European Respiratory Society and the European Coal and Steel Community. Eur Respir J 1993; 6 (Suppl.16): 1-100.
17. Groot CAR, Lammers JW, Festen J, van Herwaarden CLA. Refractoriness for ultrasonically nebulized distilled water and histamine after histamine challenge. J Appl Physiol 1991; 70: 1011-1015.
18. Bootsma GP, Dekhuijzen PNR, Festen J, Mulder P, van Herwaarden CLA. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma. Thorax 1995; 50: 1044-1050.
19. Rubin P, Dube L, Braeckman R, et al. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase. Agents Actions Suppl 1991; 35: 103-116.
20. Cockcroft DW, Killian DN, Mellon JA, Hargreave FE. Bronchial reactivity to inhaled histamine; a method and clinical survey. Clin Allergy 1977; 7: 235-243.
21. Norusis MJ. In: SPSS/PC+ 5.0 Base Manual. Chicago, SPSS Inc., 1992.
22. Pocock SJ. In: Clinical Trials: a Practical Approach. Chisester, Wiley & Sons, 1983.
23. Pauwels R, Joos G, Van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not asthma. Clin Allergy 1988; 18: 317-321.
24. Anderson SD, Smith CM. Osmotic challenges in the assessment of bronchial hyperresponsiveness. Am Rev Respir Dis 1991; 143 (Suppl.): S43-S46.
25. Mattoli S, Forensi A, Corbo GM, Valente S, Patalano F, Ciappi G. Increase in bronchial responsiveness to methacholine and late asthmatic response after inhalation of ultrasonically-nebulized distilled water. Chest 1986; 90: 726-732.
26. Bussieres S, Turcotte H, Boulet LP. Hyperosmolarity-induced increases in airway responsiveness and late asthmatic responses. Eur Respir J 1991; 4: 290-295.
27. Groot CAR, Lammers JW, Molema J, Festen J, van Herwaarden CLA. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water. Eur Respir J 1992; 5: 1075-1082.
28. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148 (Suppl.): S1-S26.
29. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 1993; 87: 133-138.
30. Meslier N, Braunstein G, Lacronique J, et al. Local cellular and humoral responses to antigenic and distilled water challenge in subjects with allergic rhinitis. Am Rev Respir Dis 1988; 137: 617-624.
31. 4, and histamine in asthmatics. Am Rev Respir Dis 1992; 146: 96-103.